Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

BORIS DOI
Publisher DOI
PubMed ID
21325445
Description
The International Breast Cancer Study Group Trial VIII compared long-term efficacy of endocrine therapy (goserelin), chemotherapy [cyclophosphamide, methotrexate and fluorouracil (CMF)], and chemoendocrine therapy (CMF followed by goserelin) for pre/perimenopausal women with lymph-node-negative breast cancer.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Karlsson, P
Sun, Z
Braun, D
Price, K N
Castiglione-Gertsch, M
Gelber, R D
Crivellari, D
Collins, J
Murray, E
Zaman, K
Colleoni, M
Gusterson, B A
Viale, G
Regan, M M
Coates, A S
Goldhirsch, A
Additional Credits
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Access(Rights)
open.access
Show full item